EFNB2 and cancer: The group identified two cell-surface proteins, a disintegrin and metalloprotease 10 (ADAM10) and ephrinB2, as drivers of fibrosis and tumor progression after radiation therapy (RT) and suggested that activation by ephrinB2 drives fibroblasts toward a myofibroblast differentiation, thereby driving cancer invasion (Mueller et al., 2021).